Telix Pharmaceuticals Limited (TLX.AX)
AUD 25.67
(-0.27%)
AUD 25.67
(-0.27%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 17.31 Million AUD | 104.2% |
| 2022 | 8.47 Million AUD | 145.43% |
| 2021 | 3.45 Million AUD | 445.66% |
| 2020 | 633 Thousand AUD | 16.79% |
| 2019 | 542 Thousand AUD | -15.65% |
| 2018 | 642.52 Thousand AUD | 116.18% |
| 2017 | 297.22 Thousand AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| 1999 | - AUD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 30.8 Million AUD | 0.0% |
| 2023 Q2 | 12.6 Million AUD | 0.0% |
| 2023 Q4 | 17.31 Million AUD | 0.0% |
| 2023 FY | 17.31 Million AUD | 104.2% |
| 2022 Q4 | 8.47 Million AUD | 0.0% |
| 2022 FY | 8.47 Million AUD | 145.43% |
| 2022 Q2 | 6.53 Million AUD | 0.0% |
| 2021 FY | 3.45 Million AUD | 445.66% |
| 2021 Q4 | 3.45 Million AUD | 0.0% |
| 2021 Q2 | 889 Thousand AUD | 0.0% |
| 2020 FY | 633 Thousand AUD | 16.79% |
| 2020 Q4 | 633 Thousand AUD | 0.0% |
| 2020 Q2 | 446 Thousand AUD | 0.0% |
| 2019 Q2 | 983.24 Thousand AUD | 0.0% |
| 2019 Q4 | 542 Thousand AUD | 0.0% |
| 2019 FY | 542 Thousand AUD | -15.65% |
| 2018 Q4 | 642.52 Thousand AUD | 0.0% |
| 2018 FY | 642.52 Thousand AUD | 116.18% |
| 2018 Q2 | - AUD | 0.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2017 FY | 297.22 Thousand AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |
| 1999 FY | - AUD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 1.4 Million AUD | -1135.374% |
| Anatara Lifesciences Ltd | -671.09 Thousand AUD | 2679.378% |
| Zelira Therapeutics Limited | 1.25 Million AUD | -1282.245% |
| Biome Australia Limited | 1.88 Million AUD | -816.563% |
| Patrys Limited | - AUD | -Infinity% |
| Orthocell Limited | 1.17 Million AUD | -1371.141% |
| Imugene Limited | - AUD | -Infinity% |
| Noxopharm Limited | -2.35 Million AUD | 833.711% |
| PYC Therapeutics Limited | -17.99 Million AUD | 196.188% |
| Chimeric Therapeutics Limited | - AUD | -Infinity% |
| Prescient Therapeutics Limited | - AUD | -Infinity% |
| Proteomics International Laboratories Limited | - AUD | -Infinity% |
| Cynata Therapeutics Limited | 108.2 Thousand AUD | -15897.56% |
| CSL Limited | 8.93 Billion AUD | 99.806% |
| Arovella Therapeutics Limited | - AUD | -Infinity% |
| Bio-Gene Technology Limited | - AUD | -Infinity% |
| Clinuvel Pharmaceuticals Limited | 10.62 Million AUD | -62.893% |
| Starpharma Holdings Limited | 2.4 Million AUD | -618.854% |
| Nanollose Limited | - AUD | -Infinity% |
| Memphasys Limited | 164.76 Thousand AUD | -10406.127% |
| Invex Therapeutics Ltd | -94.98 Thousand AUD | 18324.314% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Amplia Therapeutics Limited | - AUD | -Infinity% |
| Botanix Pharmaceuticals Limited | 1.2 Million AUD | -1331.319% |
| Island Pharmaceuticals Limited | -877.24 Thousand AUD | 2073.234% |
| Race Oncology Limited | 16.4 Thousand AUD | -105442.345% |
| Nyrada Inc. | - AUD | -Infinity% |
| Dimerix Limited | - AUD | -Infinity% |
| PharmAust Limited | - AUD | -Infinity% |
| Immutep Limited | 2.00 AUD | -865499900.0% |
| Clarity Pharmaceuticals Ltd | - AUD | -Infinity% |
| Alterity Therapeutics Limited | 1.00 AUD | -1730999900.0% |
| BTC Health Limited | - AUD | -Infinity% |
| Acrux Limited | 147 Thousand AUD | -11675.51% |
| Neuren Pharmaceuticals Limited | - AUD | -Infinity% |
| Biotron Limited | - AUD | -Infinity% |
| Tissue Repair Ltd | 214.72 Thousand AUD | -7961.587% |
| AdAlta Limited | -1.67 Million AUD | 1130.65% |
| Radiopharm Theranostics Limited | -987.41 Thousand AUD | 1853.066% |
| Hexima Limited | - AUD | -Infinity% |
| AnteoTech Limited | 221.85 Thousand AUD | -7702.323% |
| Paradigm Biopharmaceuticals Limited | - AUD | -Infinity% |
| Recce Pharmaceuticals Ltd | - AUD | -Infinity% |
| Avecho Biotechnology Limited | 97.11 Thousand AUD | -17723.862% |
| Actinogen Medical Limited | 108.82 Thousand AUD | -15805.687% |
| Immuron Limited | 1.58 Million AUD | -992.384% |
| Argenica Therapeutics Limited | - AUD | -Infinity% |